Instructions to Authors
6 November 2020
Masthead
6 November 2020
Cover Image
6 November 2020
Hepatology Highlights
Nicholas W. Russo, Robert S. Brown, Gopanandan Parthasarathy, Robert E. Schwartz, Adam Buckholz, Arun B. Jesudian, Enis Kostallari, Cesar Taborda, Joel Wedd, Tejasav S. Sehrawat, Navid Hejazifar, Lauren M. Yang, Daryl T.Y. Lau, Jessica Maiers, Nidhi Jalan‐Sakrikar – 6 November 2020
Degree of Portal and Systemic Hemodynamic Alterations Predict Recurrent AKI and Chronic Kidney Disease in Patients With Cirrhosis
Rakhi Maiwall, Samba Siva Rao Pasupuleti, Priyanka Jain, Shiv Kumar Sarin – 6 November 2020 – The relevance of hemodynamic derangements on the incidence of recurrent acute kidney injury (AKI) and chronic kidney disease (CKD) in patients with cirrhosis is largely unknown. Consecutive patients with cirrhosis with a complete record of baseline hemodynamics were followed for identifying risk factors for the development of recurrent AKI and CKD by using negative binomial regression and competing risk analysis, respectively.
HBV RNA Profiles in Patients With Chronic Hepatitis B Under Different Disease Phases and Antiviral Therapy
Lung‐Yi Mak, Gavin Cloherty, Danny Ka‐Ho Wong, Jeffrey Gersch, Wai‐Kay Seto, James Fung, Man‐Fung Yuen – 6 November 2020
Table of contents
6 November 2020
Contrast‐Enhanced Ultrasonography–Based Hepatic Perfusion for Early Prediction of Prognosis in Acute Liver Failure
Hidekatsu Kuroda, Tamami Abe, Yudai Fujiwara, Tomoaki Nagasawa, Yuji Suzuki, Keisuke Kakisaka, Yasuhiro Takikawa – 5 November 2020
Pilot Study Using Machine Learning to Identify Immune Profiles for the Prediction of Early Virological Relapse After Stopping Nucleos(t)ide Analogues in HBeAg‐Negative CHB
Maximilian Wübbolding, Juan Carlos Lopez Alfonso, Chun‐Yen Lin, Sebastian Binder, Christine Falk, Jennifer Debarry, Paul Gineste, Anke R.M.
Use of Blood Products and Drugs Before Procedures in Patients With Cirrhosis
Achintya D. Singh, Shalimar – 5 November 2020